111 related articles for article (PubMed ID: 22477194)
1. Synthesis and evaluation of peptidyl α,β-unsaturated carbonyl derivatives as anti-malarial calpain inhibitors.
Mallik SK; Li DY; Cui M; Song HO; Park H; Kim HS
Arch Pharm Res; 2012 Mar; 35(3):469-79. PubMed ID: 22477194
[TBL] [Abstract][Full Text] [Related]
2. Antimalarial effect of N-acetyl-L-Leucyl-L-leucyl-L-norleucinal by the inhibition of Plasmodium falciparum Calpain.
Jung SY; Zheng B; Choi YY; Soh BY; Kim SY; Park KI; Park H
Arch Pharm Res; 2009 Jun; 32(6):899-906. PubMed ID: 19557368
[TBL] [Abstract][Full Text] [Related]
3. Anti-malarial activity of new N-acetyl-L-leucyl-L-leucyl-L-norleucinal (ALLN) derivatives against Plasmodium falciparum.
Choi HJ; Cui M; Li DY; Song HO; Kim HS; Park H
Bioorg Med Chem Lett; 2013 Mar; 23(5):1293-6. PubMed ID: 23357632
[TBL] [Abstract][Full Text] [Related]
4. Specific calpain activity evaluation in Plasmodium parasites.
Gomes MM; Budu A; Ventura PD; Bagnaresi P; Cotrin SS; Cunha RL; Carmona AK; Juliano L; Gazarini ML
Anal Biochem; 2015 Jan; 468():22-7. PubMed ID: 25281458
[TBL] [Abstract][Full Text] [Related]
5. BDA-410: a novel synthetic calpain inhibitor active against blood stage malaria.
Li X; Chen H; Jeong JJ; Chishti AH
Mol Biochem Parasitol; 2007 Sep; 155(1):26-32. PubMed ID: 17583361
[TBL] [Abstract][Full Text] [Related]
6. Identification and structure-activity relationship (SAR) studies of carvacrol derivatives as potential anti-malarial against Plasmodium falciparum falcipain-2 protease.
Uddin A; Singh V; Irfan I; Mohammad T; Singh Hada R; Imtaiyaz Hassan M; Abid M; Singh S
Bioorg Chem; 2020 Oct; 103():104142. PubMed ID: 32763521
[TBL] [Abstract][Full Text] [Related]
7. Tripeptide analogues of MG132 as protease inhibitors.
Pehere AD; Nguyen S; Garlick SK; Wilson DW; Hudson I; Sykes MJ; Morton JD; Abell AD
Bioorg Med Chem; 2019 Jan; 27(2):436-441. PubMed ID: 30581047
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel class of falcipain-2 inhibitors as potential antimalarial agents.
Chakka SK; Kalamuddin M; Sundararaman S; Wei L; Mundra S; Mahesh R; Malhotra P; Mohmmed A; Kotra LP
Bioorg Med Chem; 2015 May; 23(9):2221-40. PubMed ID: 25840796
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity-relationship studies of thiazolidinediones as antiplasmodial inhibitors of the Plasmodium falciparum cysteine protease falcipain-2.
Sharma RK; Younis Y; Mugumbate G; Njoroge M; Gut J; Rosenthal PJ; Chibale K
Eur J Med Chem; 2015 Jan; 90():507-18. PubMed ID: 25486422
[TBL] [Abstract][Full Text] [Related]
10. Pyrido[1,2-a]pyrimidin-4-ones as antiplasmodial falcipain-2 inhibitors.
Mane UR; Li H; Huang J; Gupta RC; Nadkarni SS; Giridhar R; Naik PP; Yadav MR
Bioorg Med Chem; 2012 Nov; 20(21):6296-304. PubMed ID: 23040894
[TBL] [Abstract][Full Text] [Related]
11. Identification of active Plasmodium falciparum calpain to establish screening system for Pf-calpain-based drug development.
Soh BY; Song HO; Lee Y; Lee J; Kaewintajuk K; Lee B; Choi YY; Cho JH; Choi S; Park H
Malar J; 2013 Feb; 12():47. PubMed ID: 23374507
[TBL] [Abstract][Full Text] [Related]
12. Structure-based approach to falcipain-2 inhibitors: synthesis and biological evaluation of 1,6,7-trisubstituted dihydroisoquinolines and isoquinolines.
Batra S; Sabnis YA; Rosenthal PJ; Avery MA
Bioorg Med Chem; 2003 May; 11(10):2293-9. PubMed ID: 12713840
[TBL] [Abstract][Full Text] [Related]
13. Effect of calpain inhibitors on the invasion of human erythrocytes by the parasite Plasmodium falciparum.
Olaya P; Wasserman M
Biochim Biophys Acta; 1991 Apr; 1096(3):217-21. PubMed ID: 2018795
[TBL] [Abstract][Full Text] [Related]
14. Falcipain inhibitors: optimization studies of the 2-pyrimidinecarbonitrile lead series.
Coterón JM; Catterick D; Castro J; Chaparro MJ; Díaz B; Fernández E; Ferrer S; Gamo FJ; Gordo M; Gut J; de las Heras L; Legac J; Marco M; Miguel J; Muñoz V; Porras E; de la Rosa JC; Ruiz JR; Sandoval E; Ventosa P; Rosenthal PJ; Fiandor JM
J Med Chem; 2010 Aug; 53(16):6129-52. PubMed ID: 20672841
[TBL] [Abstract][Full Text] [Related]
15. Stage-specific antimalarial activity of cysteine protease inhibitors.
Shenai BR; Semenov AV; Rosenthal PJ
Biol Chem; 2002 May; 383(5):843-7. PubMed ID: 12108550
[TBL] [Abstract][Full Text] [Related]
16. Hypervalent organotellurium compounds as inhibitors of P. falciparum calcium-dependent cysteine proteases.
El Chamy Maluf S; Melo PMS; Varotti FP; Gazarini ML; Cunha RLOR; Carmona AK
Parasitol Int; 2016 Feb; 65(1):20-22. PubMed ID: 26384965
[TBL] [Abstract][Full Text] [Related]
17. Peptide alpha-keto ester, alpha-keto amide, and alpha-keto acid inhibitors of calpains and other cysteine proteases.
Li Z; Patil GS; Golubski ZE; Hori H; Tehrani K; Foreman JE; Eveleth DD; Bartus RT; Powers JC
J Med Chem; 1993 Oct; 36(22):3472-80. PubMed ID: 8230139
[TBL] [Abstract][Full Text] [Related]
18. Synthetic compounds from an in house library as inhibitors of falcipain-2 from Plasmodium falciparum.
Bertoldo JB; Chiaradia-Delatorre LD; Mascarello A; Leal PC; Cordeiro MN; Nunes RJ; Sarduy ES; Rosenthal PJ; Terenzi H
J Enzyme Inhib Med Chem; 2015 Apr; 30(2):299-307. PubMed ID: 24964346
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and anti-malarial activities of synthetic analogs of biselyngbyolide B, a Ca
Sato E; Morita M; Ogawa H; Iwatsuki M; Hokari R; Ishiyama A; Ōmura S; Iwasaki A; Suenaga K
Bioorg Med Chem Lett; 2018 Feb; 28(3):298-301. PubMed ID: 29292225
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and in vitro evaluation of imidazopyridazines as novel inhibitors of the malarial kinase PfPK7.
Bouloc N; Large JM; Smiljanic E; Whalley D; Ansell KH; Edlin CD; Bryans JS
Bioorg Med Chem Lett; 2008 Oct; 18(19):5294-8. PubMed ID: 18774709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
